Formulation of liposomes associated with recombinant interleukin-2: Effect on interleukin-2 activity

Biomedicine and Pharmacotherapy

Volumn 58, Issue 3, 2004, Pages 162-167

  Pellequer, Yann ^a   Ollivon, Michel ^a   Barratt, Gillian ^a  

^a UNIV PARIS SUD   (France)

Author keywords

CTLL 2 proliferation; Dipalmitoylphosphatidylcholine; DPPC; Interleukin 2; Large unilamellar vesicles; Liposomes; LUV; MLV; Multilamellar vesicles; N octyl ,D glucopyranoside; OG; Recombinant human interleukin 2; RIL 2; Small unilamellar vesicles; SUV

Indexed keywords

DIPALMITOYLPHOSPHATIDYLCHOLINE; LIPOSOME; RECOMBINANT INTERLEUKIN 2; RU 49637;

ANIMAL CELL; ARTICLE; DIMERIZATION; DRUG ACTIVITY; HEATING; LIPID VESICLE; LYMPHOCYTE PROLIFERATION; MECHANICAL PROBE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REDUCTION; ULTRASOUND;

EID: 1842735217     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2003.12.008     Document Type: Article

References (21)

1. Advant S.J., Braswell E.H., Kumar C.V., Kalonia D.S. The effect of pH and temperature on the self-association of recombinant human interleukin-2 as studied by equilibrium sedimentation. Pharm Res. 12:1995;637-641.
2. Anderson P.M., Katsanis E., Sencer S.F., Hasz D., Ochoa A.C., Bostrom B. Depot characteristics and biodistribution of interleukin-2 liposomes: importance of route of administration. J Immunother. 12:1992;19.
3. Bergers J.J., Den Otter W., Dullens H.F., Kerkvliet C.T., Crommelin D.J. Interleukin-2-containing liposomes: interaction of interleukin-2 with liposomal bilayers and preliminary studies on application in cancer vaccines. Pharm Res. 10:1993;1715.
4. Bergmann C.A., Landmeier B.J., Kaplan D.R. Phase separation analysis of recombinant interleukin 2. Mol Immunol. 28:1991;99-105.
5. Castignolles N., Betbeder D., Ioualalen K., Merten O., Leclerc C., Samain D., et al. Stabilization and enhancement of interleukin-2 in vitro bioactivity by new carriers: supramolecular biovectors. Vaccine. 12:1994;1413.
6. Fleischmann J.D., Wentworth D., Valencic F., Imbembo A.L., Koehler K.A. Interleukin-2 self-association. Biochem Biophys Res Commun. 152:1988;879-885.
7. Fleury L. 1993;Thesis University, Paris Sud.
8. Fleury L., Ollivon M., Dubois J.L., Puisieux F., Barratt G. Preparation and characterization of dipalmitoylphosphatidylcholine liposomes containing interleukin-2. Braz J Med Biol Res. 28:1995;519-529.
9. Kaplan D., Smith D., Huang R., Yildirim Z. Self-association of interleukin 2 bound to its receptor. Faseb J. 9:1995;1096-1102.
10. Kaplan D.R. Delivery of interleukin 2 for immunotherapy. J Chromatogr B. 662:1994;315-323.
11. Kedar E., Gur H., Babai I., Samira S., Even-Chen S., Barenholz Y. Delivery of cytokines by liposomes: hematopoietic and immunomodulatory activity of interleukin-2 encapsulated in conventional liposomes and long-circulating liposomes. J Immunother. 23:2000;131.
12. Khanna C., Anderson P.M., Hasz D.E., Katsanis E., Neville M., Klausner J.S. Interleukin-2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastases. Cancer. 79:1997;1409.
13. Koppenhagen F.J., Balemans L.T.M., Steerenberg P.A., Jagmont T.M., Den Otter W., Storm G. The design of a pharmaceutically acceptable liposomal formulation of recombinant interleukin-2 (rIL-2) for locoregional anticancer immunotherapy. J Liposome Res. 9:1999;313.
14. Koppenhagen F.J., Visser A.J., Herron J.N., Storm G., Crommelin D.J. Interaction of recombinant interleukin-2 with liposomal bilayers. J Pharm Sci. 87:1998;707-714.
15. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680.
16. Liu L.S., Liu S.Q., Ng S., Heller J., Froix M. The potential application of alginate/chitosan porous microsphere loaded with interleukin-2 in tumour immunotherapy. Proceed Intern Symp Control Rel Bioact Mater. 22:1995;542.
17. Matsuoka J., Sakagami K., Shiozaki S., Uchida S., Fujiwara T., Gohchi A., et al. Development of an interleukin-2 slow delivery system. ASAIO Trans. 34:1988;729.
18. Moya G., Gonzalez L.J., Huerta V., Garcia Y., Morera V., Perez D., et al. Isolation and characterization of modified species of a mutated (Cys125-Ala) recombinant human interleukin-2. J Chromatogr A. 971:2002;129-142.
19. Pellequer Y., Ollivon M., Barratt G. Methodology for assaying recombinant interleukin-2 associated with liposomes by combined gel exclusion chromatography and fluorescence. J Chromatogr B. 783:2003;151-162.
20. Vaage J., Mayhew E. Immunotherapy of a mouse mammary carcinoma by sustained peritumor release of IL-2. Int J Cancer. 47:1991;582-585.
21. Wray W., Boulikas T., Wray V.P., Hancok R. Silver staining of proteins in polyacrylamide gels. Anal Biochem. 118:1981;197.